Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$25.00 Web:$22.50 add to cart PDF BOOK your price: $19.50 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients) From Cancer Patient to Cancer Survivor: Lost in Transition Other Related Titles An Assessment of the NIH Women's Health Initiative (1993) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 133   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. K Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators Clinical Coordinating Center Ross L. Prentice, Ph.D. Fred Hutchinson Cancer Research Center Seattle, Washington Vanguard Clinical Centers Gregory L. Burke, M.D., M.S. The Bowman Gray School of Medicine Winston-Salem, North Carolina JoAnn Manson, M.D., Dr.P.H. Brigham and Women's Hospital Boston Maurizio Trevisan, M.D., M.S. State University of New York, Buffalo Albert Oberman, M.D. * University of Alabama Birmingham Thomas E. Moon, Ph.D. University of Arizona W. Dallas Hall, M.D. * Emory University School of Medicine Maureen Henderson, M.D. Fred Hutchinson Cancer Research Center Seattle, Washington Annlouise R. Assaf, Ph.D. The Memorial Hospital Pawtucket, Rhode Island Philip Greenland, M.D. Northwestern University Medical School John A. Robbins, M.D. University of California, Davis Robert D. Langer, M.D., M.P.H. * University of California, San Diego * These Vanguard Clinical Centers will recruit primarily minority populations. Page 133 Front Matter (R1-R16) Executive Summary (1-18) Introduction (19-24) Clinical Trial (25-76) Observational Study (77-80) Community Prevention Study (81-84) Concluding Remarks (85-90) References (91-94) Appendix A: Clinical Trial Exclusion Criteria (95-100) Appendix B: U.S. House of Representatives Appropriations COmmittee (101-102) Appendix C: Statement of Task (103-104) Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health (105-108) Appendix E: Meeting Participants June, July, and August 1993 (109-112) Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial (113-114) Appendix G: Women's Health Initiative Committees (115-116) Appendix H: NIH-Sponsored Women's Health Studies (117-122) Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers (123-126) Appendix J: NIH Power Calculations (127-132) Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators (133-134) Appendix L: Abbreviations and Acronyms (135-136) Appendix M: Committee and Staff Biographies (137-142)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 133
An Assessment of the NIH Women's Health Initiative K Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators Clinical Coordinating Center Ross L. Prentice, Ph.D. Fred Hutchinson Cancer Research Center Seattle, Washington Vanguard Clinical Centers Gregory L. Burke, M.D., M.S. The Bowman Gray School of Medicine Winston-Salem, North Carolina JoAnn Manson, M.D., Dr.P.H. Brigham and Women's Hospital Boston Maurizio Trevisan, M.D., M.S. State University of New York, Buffalo Albert Oberman, M.D. * University of Alabama Birmingham Thomas E. Moon, Ph.D. University of Arizona W. Dallas Hall, M.D. * Emory University School of Medicine Maureen Henderson, M.D. Fred Hutchinson Cancer Research Center Seattle, Washington Annlouise R. Assaf, Ph.D. The Memorial Hospital Pawtucket, Rhode Island Philip Greenland, M.D. Northwestern University Medical School John A. Robbins, M.D. University of California, Davis Robert D. Langer, M.D., M.P.H. * University of California, San Diego * These Vanguard Clinical Centers will recruit primarily minority populations.

OCR for page 134
An Assessment of the NIH Women's Health Initiative Norman L. Lasser, M.D. University of Medicine and Dentistry of New Jersey Robert Wallace, MD University of Iowa Richard H. Grimm, M.D. University of Minnesota Medical School Lewis H. Kuller, M.D. University of Pittsburgh William B. Applegate, M.D. University of Tennessee, Memphis

Representative terms from entire chapter:

clinical centers